| Literature DB >> 31340346 |
Bernarda Sánchez-Jiménez1, Gabriela Chico-Barba2,3, Ana Lilia Rodríguez-Ventura2, Reyna Sámano2, Daniela Veruete-Bedolla4, Rosa María Morales-Hernández2.
Abstract
OBJECTIVE: to detect the risk of development of type 2 diabetes in nurses and its relationship with metabolic alterations.Entities:
Mesh:
Year: 2019 PMID: 31340346 PMCID: PMC6687365 DOI: 10.1590/1518-8345.3002.3161
Source DB: PubMed Journal: Rev Lat Am Enfermagem ISSN: 0104-1169
General characteristics of the nurses according to category of risk for type 2 diabetes, based on FINDRISC*. Mexico City, Mexico, 2016-2017
| Variable | Risk for Type 2 Diabetes | ||||||
|---|---|---|---|---|---|---|---|
| Low | Slightly elevated | Moderate | High | Very high | p- Value | ||
| (n=12) | (n=51) | (n=41) | (n=44) | (n=7) | |||
| Age (years) | |||||||
| <45 | 9(11) | 28(35) | 23(28) | 18(22) | 3(4) | 0.249 | |
| ≥45 | 3 (4) | 23 (31) | 18(24) | 26(35) | 4(5) | ||
| Schooling | |||||||
| Technical (General) | 2(4) | 14(26) | 14(26) | 23(42) | 1(2) | 0.121 | |
| University degree | 5(8) | 23(35) | 18(28) | 14(21) | 5(8) | ||
| Master's/doctorate | 5(14) | 14(39) | 9(25) | 7(19) | 1(3) | ||
| Marital status | |||||||
| Married | 4(4) | 33(34) | 28(29) | 27(28) | 5(5) | ||
| Single | 8(14) | 18(31) | 13(23) | 17(29) | 2(3) | 0.256 | |
| Shift | |||||||
| Morning | 9(9) | 30(30) | 28(29) | 28(29) | 3(3) | 0.736 | |
| Evening | 1(7) | 5(35) | 4(29) | 4(29) | 0 | ||
| Night | 2(5) | 16(37) | 9(21) | 12(28) | 4(9) | ||
| Type of Patient | |||||||
| Serious | 8(9) | 34(36) | 28(30) | 21(22) | 3(3) | 0.080 | |
| Non-serious | 3(12) | 6(24) | 7(28) | 6(24) | 3(12) | ||
| Outpatient and without contact with patient | 1(3) | 11(30) | 6(17) | 17(47) | 1(3) | ||
| Years of Professional Experience | 16.5(5.2-26) | 21(10-26) | 24(18.5-26) | 25(19.5-29) | 28(15-31) | 0.103 | |
FINDRISC = Finnish Diabetes Risk Score;
Data expressed as frequency (%), Pearson's Chi-squared test;
Data expressed as median (p25-p75), Kruskal-Wallis test
Clinical characteristics of the nurses according to the risk category for type 2 diabetes, based on FINDRISC*. Mexico City, Mexico, 2016-2017
| Variable | Risk for Type 2 Diabetes | |||||
|---|---|---|---|---|---|---|
| Low | Slightly elevated | Moderate | High | Very high | p-Value | |
| (n=12) | (n=51) | (n=41) | (n=44) | (n=7) | ||
| BMI (kg/m2) | 23.8 | 26.5 | 28.2 | 29.8 | 33.1 | <0.01 |
| (22.9-26.0) | (25-28.6) | (26.1-31.2) | (27.1-35.6) | (28.1-36.5) | ||
| Waist (cm) | 78 | 85.4 | 89.1 | 92.2 | 99 | <0.01 |
| (75.1-79.5) | (80.5-90) | (83.2-95) | (87.1-100) | (87-101) | ||
| Waist-Hip Ratio | 0.81 | 0.85 | 0.86 | 0.87 | 0.87 | <0.01 |
| (0.76-0.86) | (0.82-0.88) | (0.81-0.89) | (0.83-0.90) | (0.85-0.92) | ||
FINDRISC = Finnish Diabetes Risk Score;
Data expressed as median (p25-p75), Kruskal-Wallis test
Biochemical profile of the nurses according to risk category for type 2 diabetes, based on FINDRISC*. Mexico City, Mexico, 2016-2017
| Variable | Risk for Type 2 Diabetes | |||||
|---|---|---|---|---|---|---|
| Low | Slightly elevated | Moderate | High | Very high | p-Value | |
| (n=12) | (n=51) | (n=41) | (n=44) | (n=7) | ||
| Fasting glycemia | 92.6 | 92 | 92 | 99.2 | 106 | <0.01 |
| (mg/dL) | (85.0-96.8) | (86.7-97.3) | (85-97.2) | (91.7-107) | (96-109) | |
| Insulin | 5.6 | 10.1 | 11 | 16.4 | 19 | <0.01 |
| (I.U.) | (4.6-6.7) | (6.6-15.7) | (7.3-18.9) | (12-27) | (12-25) | |
| HbA1c | 5.5 | 5.5 | 5.6 | 5.7 | 6 | 0.018 |
| (%) | (5.3-5.8) | (5.4-5.7) | (5.4-5.8) | (5.5-6) | (5.5-6.1) | |
| HOMA | 1.3 | 2.4 | 2.3 | 4.2 | 4.5 | 0.001 |
| Index | (1-1.5) | (1.4-3.6) | (1.7-4.4) | (3-7.2) | (3-6.6) | |
| Triglycerides | 121.5 | 114 | 112 | 165 | 147 | <0.01 |
| (mg/dL) | (93-144.2) | (94-182) | (101.5-164) | (131-208.2) | (124-171) | |
| Total Cholesterol | 193 | 193 | 187 | 186 | 222 | 0.044 |
| (mg/dL) | (167.7-208.2) | (163-210) | (170.5-204) | (175.2-206.7) | (203-293) | |
| HDL Cholesterol | 51.8 | 46.7 | 46.3 | 42.8 | 52.2 | 0.017 |
| (mg/dL) | (46.8-63.3) | (41.5-58) | (42.8-52.8) | (39.8-49.8) | (45-63) | |
| LDL Cholesterol | 107.5 | 117.8 | 108.2 | 108.2 | 142 | 0.022 |
| (mg/dL) | (96-122.3) | (93.7-128.6) | (100.4-122) | (100.2-126.4) | (137-202.1) | |
FINDRISC = Finnish Diabetes Risk Score;
Data expressed as median (p25-p75), Comparison between medians by Kruskal-Wallis;
HOMA Index = insulin resistance index (Homeostatic Model Assessment)